4.4 Article

Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Population Pharmacokinetic-Pharmacogenetic Study of Nevirapine in HIV-Infected Cambodian Patients

Monidarin Chou et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Biotechnology & Applied Microbiology

HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients

Soranun Chantarangsu et al.

PHARMACOGENETICS AND GENOMICS (2009)

Article Infectious Diseases

HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients

Sirirat Likanonsakul et al.

AIDS Research and Therapy (2009)

Article Chemistry, Medicinal

Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash

Jie Chen et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2008)

Letter Immunology

HLA-Cw8 primarily associated with hypersensitivity to nevirapine

Hiroyuki Gatanaga et al.

Article Pharmacology & Pharmacy

RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity

A. Walubo et al.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2006)

Letter Immunology

Appropriate use of nevirapine for long-term therapy

J Leith et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

Article Genetics & Heredity

Replication validity of genetic association studies

JPA Ioannidis et al.

NATURE GENETICS (2001)